Journal
FUTURE ONCOLOGY
Volume 12, Issue 8, Pages 1067-1080Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/fon.16.4
Keywords
adverse effects; angiogenesis inhibitors; anti-VEGF therapy; cardiovascular; tyrosine kinase inhibitors
Categories
Ask authors/readers for more resources
Anticancer treatment has evolved enormously over the last decade. Drugs targeting receptor tyrosine kinases, VEGFR and EGFR have changed the treatment landscape of certain cancers and have shifted the theme of anticancer therapy toward personalized care. However, these newer agents also come with unique side-effect profiles not seen with conventional chemotherapy including serious cardiovascular adverse effects. Hence, meticulous understanding of the adverse effects is crucial in maximizing clinical benefits and minimizing detrimental effects of these newer drugs. We have reviewed the cardiovascular adverse effects of anti-VEGF therapy in this article.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available